BALCAO · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · SMALL CAP
Cannabis Bioscience International Holdings, Inc. CBIH
3 fiscal years on record · USD · FY2024 reported · SEC filings only
$-548,820
In brief
What this company does
Written from the business description in Cannabis Bioscience International Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 22 September 2025. Every sentence was checked against that document before publication.
Growth
USD 303,022.00
Revenue, FY2024 · full 3-year series below
Revenue $M
Net income $M
FY2024 · Revenue 0.3 · Net income -0.5
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−181 cents
lost on every revenue dollar
Operating margin
Net margin
FY2024 · Operating -139.1% · Net -181.1%
ROE
Not applicable: equity was negative in this period, so return on equity has no meaning.
The 3-year record
3 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 |
| EBITDA $B | · | · | · |
| Income tax $B | · | 0.0 | 0.0 |
| Net income $B | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.00 | −0.00 | −0.00 |
| Dividend / sh $ | · | · | · |
| Payout % | · | · | · |
| ROE % | · | · | · |
| Shares out B | 11.63 | 10.43 | 10.06 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 15 reconciliationsAUDITED
Reconciled in 3 of 19 fiscal years. 80 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Commercial Physical & Biological Research
Listed onOTC market
Incorporated inColorado
Fiscal year endsMay 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2022